Fuller & Thaler Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-200
| Closed | -$69K | – | 673 |
|
|
2018
Q2 | $69K | Hold |
200
| – | – | ﹤0.01% | 652 |
|
|
2018
Q1 | $69K | Buy |
+200
| New | +$69K | ﹤0.01% | 638 |
|
|
2017
Q1 | – | Sell |
-700
| Closed | -$257K | – | 743 |
|
|
2016
Q4 | $257K | Hold |
700
| – | – | ﹤0.01% | 354 |
|
|
2016
Q3 | $281K | Buy |
700
+300
| +75% | +$120K | ﹤0.01% | 303 |
|
|
2016
Q2 | $140K | Buy |
+400
| New | +$140K | ﹤0.01% | 370 |
|
|
2015
Q3 | – | Sell |
-300
| Closed | -$153K | – | 741 |
|
|
2015
Q2 | $153K | Sell |
300
-200
| -40% | -$102K | ﹤0.01% | 453 |
|
|
2015
Q1 | $226K | Sell |
500
-700
| -58% | -$316K | 0.01% | 393 |
|
|
2014
Q4 | $492K | Buy |
1,200
+500
| +71% | +$205K | 0.02% | 316 |
|
|
2014
Q3 | $252K | Buy |
700
+200
| +40% | +$72K | 0.01% | 398 |
|
|
2014
Q2 | $141K | Sell |
500
-1,100
| -69% | -$310K | 0.01% | 512 |
|
|
2014
Q1 | $480K | Buy |
1,600
+1,000
| +167% | +$300K | 0.02% | 322 |
|
|
2013
Q4 | $165K | Hold |
600
| – | – | 0.01% | 431 |
|
|
2013
Q3 | $188K | Sell |
600
-26,100
| -98% | -$8.18M | 0.01% | 389 |
|
|
2013
Q2 | $6M | Buy |
+26,700
| New | +$6M | 0.42% | 102 |
|